8-K
Current Report
Ernexa Therapeutics Inc. Filed Acc 0001019687-08-005195
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ntn_8k-111608.htm…